Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J G Thirion

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoringAbdullah Aljutayli, Daniel J G Thirion, Fahima Nekka
BMC Public Health|September 23, 2023
Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping reviewAlexandre Chadi, Daniel J G Thirion, Pierre-Marie David
European Journal of Drug Metabolism and Pharmacokinetics|July 29, 2025
Population Pharmacokinetic Model Evaluation with a Small Real-World Dataset Versus a Large Virtual Dataset: Does Sample Size Affect Decision-Making?Mehdi El Hassani, Daniel J G Thirion, Amélie Marsot
Pharmacotherapy|May 24, 2006
Telithromycin-induced digoxin toxicity and electrocardiographic changesLaura M Nenciu, Patrice Laberge, Daniel J G Thirion
Infection Control and Hospital Epidemiology|October 4, 2016
Impact of an Infection Control and Antimicrobial Stewardship Program on Solid Organ Transplantation and Hepatobiliary Surgical Site InfectionsCharles Frenette, David Sperlea, Yveta Leharova, et al.
Clinical and Translational Science|February 16, 2022
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulationsAbdullah Aljutayli, Daniel J G Thirion, Guillaume Bonnefois, et al.
Therapeutic Drug Monitoring|September 7, 2022
New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic AnalysisKevin Koloskoff, Daniel J G Thirion, Elias Matouk, et al.
Pediatric Pulmonology|March 3, 2020
Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic modelDaniel J G Thirion, Valérian Pasche, Elias Matouk, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 14, 2024
Key stakeholder perspectives on delivery of vaccination services in Quebec community pharmaciesAlexandre Chadi, Daniel J G Thirion, Nancy M Waite, et al.
Journal of Chemotherapy (Florence, Italy)|March 3, 2022
Aminoglycosides' dosing and monitoring practices in critically ill patients in Quebec hospitalsAlexandre Duong, Daniel J G Thirion, David Williamson, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoringAbdullah Aljutayli, Daniel J G Thirion, Fahima Nekka
BMC Public Health|September 23, 2023
Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping reviewAlexandre Chadi, Daniel J G Thirion, Pierre-Marie David
European Journal of Drug Metabolism and Pharmacokinetics|July 29, 2025
Population Pharmacokinetic Model Evaluation with a Small Real-World Dataset Versus a Large Virtual Dataset: Does Sample Size Affect Decision-Making?Mehdi El Hassani, Daniel J G Thirion, Amélie Marsot
Pharmacotherapy|May 24, 2006
Telithromycin-induced digoxin toxicity and electrocardiographic changesLaura M Nenciu, Patrice Laberge, Daniel J G Thirion
Infection Control and Hospital Epidemiology|October 4, 2016
Impact of an Infection Control and Antimicrobial Stewardship Program on Solid Organ Transplantation and Hepatobiliary Surgical Site InfectionsCharles Frenette, David Sperlea, Yveta Leharova, et al.
Clinical and Translational Science|February 16, 2022
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulationsAbdullah Aljutayli, Daniel J G Thirion, Guillaume Bonnefois, et al.
Therapeutic Drug Monitoring|September 7, 2022
New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic AnalysisKevin Koloskoff, Daniel J G Thirion, Elias Matouk, et al.
Pediatric Pulmonology|March 3, 2020
Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic modelDaniel J G Thirion, Valérian Pasche, Elias Matouk, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 14, 2024
Key stakeholder perspectives on delivery of vaccination services in Quebec community pharmaciesAlexandre Chadi, Daniel J G Thirion, Nancy M Waite, et al.
Journal of Chemotherapy (Florence, Italy)|March 3, 2022
Aminoglycosides' dosing and monitoring practices in critically ill patients in Quebec hospitalsAlexandre Duong, Daniel J G Thirion, David Williamson, et al.
Pageof 3